Research Abstract Database
Hematology and Oncology
Dual Inhibition of BER by TRC102 and PARP Inhibitor (ABT 888) Synergistically Enhances Cytotoxicity of TMZ in Human Melanoma
Hematology and Oncology
Dual Inhibition of BER by TRC102 and PARP Inhibitor (ABT 888) Synergistically Enhances Cytotoxicity of TMZ in Human Melanoma
Research Abstract Database
| Research Abstract Database | Search |
Dual Inhibition of BER by TRC102 and PARP Inhibitor (ABT 888) Synergistically Enhances Cytotoxicity of TMZ in Human Melanoma |
|
Author: Bulgar, Alina Author's Email: axb187@case.edu Mentor: Liu, Lili Project Type: basic research Keyword: melanoma, skin cancer, temozolomide, DNA, cell Author's Position: post-doc Year Presented: 2018 |
![]() | |
- Research Overview
- Research Day
- Research Abstract Database
- Team Science Challenge
- Research Resources
- Center for Clinical Research and Technology
- Clinical & Translational Science Collaborative
- Clinical Research Scholars Program
- K99 Awards
- Medical Student Research Opportunities
- Harrington Fellows Program
- Clinical Trial Search
